Changeflow GovPing Healthcare & Life Sciences HSML P.C. Files Patent Extension for SAN-EI GEN...
Routine Notice Added Final

HSML P.C. Files Patent Extension for SAN-EI GEN F.F.I. Inc.

Email

Summary

HSML P.C. submitted a patent term extension application to the FDA on behalf of SAN-EI GEN F.F.I. Inc. The filing is associated with docket FDA-2026-E-4491-0004 and has been logged in the CDER document system. The source page indicates no documents are currently available for public viewing or download; the underlying patent extension application is accessible only as an attachment to this docket entry.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

Every FDA document on regulations.gov, the federal rulemaking portal. This is where the agency posts variances, advisory committee meeting notices, draft guidance for comment, citizen petition responses, and procedural rules that do not get a separate Federal Register slot. Around 240 a month. FDA's heavy regulations.gov use means tracking only the Federal Register misses a meaningful chunk of what the agency does day-to-day. Watch this if you manufacture devices, submit IND or NDA applications, run a lab, or advise sponsors on FDA process. GovPing publishes each posting with the docket, document type, division (CDER, CDRH, CFSAN), and comment window where one applies.

What changed

The FDA docket system received and logged a patent term extension application filed by HSML P.C. on behalf of SAN-EI GEN F.F.I. Inc. The filing is catalogued under CDER with no underlying documents available for public download through the regulations.gov interface. This represents a routine patent administrative filing rather than a substantive regulatory action.

Pharmaceutical companies and patent holders seeking patent term extensions under applicable statutory provisions should monitor this docket for any subsequent FDA actions or requests for additional information. The absence of downloadable documents suggests the substantive application materials may not yet be publicly available or may require direct contact with the filer for access.

Archived snapshot

Apr 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 1

Patent Term Extension Application from HSML P.C. on behalf of SAN-EI GEN F.F.I. Inc.

More Information
- Author(s) CDER
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Docket
FDA-2026-E-4491-0004

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent extension filing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Regulatory Affairs
Topics
Pharmaceuticals

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!